YOLFTbeta
OssDsign AB

OssDsign AB

OSSD · ST · Healthcare / Medical Devices

3.50SEK+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close3.50
Open3.49
Day Range3.48 – 3.55
52-Week Range3.34 – 13.98
Volume126.16K
Market Cap385.53M
P/E (TTM)0.00
Forward P/E31.95
EPS-0.50
Dividend Yield0.00%
Beta0.62
50-Day Avg3.84
200-Day Avg5.41

About

OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in the United States. The company offers OssDsign Catalyst, a nanosynthetic bone graft engages in dual bone formation pathways through fusion mass. OssDsign AB (publ) was founded in 2011 and is headquartered in Uppsala, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Mark Waugh B.S., M.B.A.
  • Employees41
  • HeadquartersUlls väg 29C, Uppsala, Sweden, 756 51, Sweden
  • Websitehttps://www.ossdsign.com

Leadership

  • Mr. Mark Waugh B.S., M.B.A.Chief Executive Officer
  • Mr. Anders SvenssonChief Financial Officer · b. 1963
  • Dr. Tom Buckland Ph.D.Chief Technical Officer · b. 1972
  • Mr. Stephen AndersonVice President of Marketing · b. 1976
  • Mr. Adam McCollisterVice President of Sales
  • Ms. Melanie MarshallVice President of Clinical & Medical Affairs · b. 1979
  • Mr. Eric PatermoVice President of Sales US · b. 1969

Financials

Income Statement

Currency: SEK2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue4.19M7.68M13.26M16.87M24.87M31.73M56.98M112.16M133.94M180.16M
Growth (%)-+83.12%+72.66%+27.21%+47.41%+27.56%+79.62%+96.82%+19.42%+34.51%
Cost of Revenue42.61M-5.67M-1.75M7.11M8.87M10.88M11.85M28.51M6.19M6.69M
Gross Profit-38.42M13.35M15.01M9.76M16.00M20.84M45.13M83.64M127.75M173.47M
Gross Margin-915.77%173.82%113.19%57.87%64.34%65.70%79.20%74.58%95.38%96.29%
Operating Expense354.74M65.16M93.29M99.94M110.54M135.63M175.60M177.18M221.83M
Operating Income-38.42M-41.38M-50.15M-83.53M-83.93M-89.70M-90.49M-91.96M-49.43M-48.36M
Operating Margin-915.77%-538.73%-378.05%-495.03%-337.46%-282.74%-158.80%-81.99%-36.90%-26.84%
EBITDA-36.29M-38.57M-47.90M-81.61M-80.64M-79.97M-89.41M-122.02M-45.31M-44.30M
EBITDA Margin-865.12%-502.10%-361.16%-483.64%-324.21%-252.06%-156.90%-108.79%-33.83%-24.59%
Net Income-28.51M-63.27M-56.01M-84.25M-84.59M-93.92M-99.39M-130.49M-49.66M-50.99M
Net Income Margin-679.74%-823.64%-422.28%-499.29%-340.10%-296.03%-174.41%-116.35%-37.07%-28.30%
R&D---2.18M3.28M3.19M3.19M30.34M22.82M20.12M
R&D as % of Total Revenue---12.91%13.20%10.05%5.59%27.05%17.04%11.17%
Interest Expense181.61K3.11M5.72M226.00K608.00K4.43M9.43M3.74M103.00K46.00K
Interest Expense % of Total Revenue4.33%40.43%43.09%1.34%2.44%13.96%16.54%3.33%0.08%0.03%

Balance Sheet

Currency: SEK2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets38.63M70.18M75.12M153.27M246.65M343.99M339.50M356.39M307.42M397.87M
Total Liabilities10.85M19.76M27.63M17.99M134.58M81.26M91.39M105.26M93.36M87.84M
Total Equity27.77M50.42M47.49M135.28M112.07M262.72M248.11M251.13M214.06M310.03M
Cash16.31M35.23M14.08M113.54M49.40M151.37M124.65M165.94M100.86M191.35M
Total Debt3.85M10.07M9.44M4.55M17.24M14.13M13.60M3.15M1.97M1.37M
Net Debt-12.46M-25.16M-4.64M-108.99M-32.16M-137.23M-111.05M-162.79M-98.89M-189.97M

Cash Flow

Currency: SEK2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-40.61M-66.05M-86.59M-79.10M-89.78M-89.23M-93.91M-62.38M-64.03M
Investing Cash Flow-10.55M-7.66M-326.00K-17.67M-51.85M-129.00K-124.00K-657.00K-7.40M
Financing Cash Flow70.09M52.55M186.31M33.18M243.43M61.84M135.40M-2.46M163.18M
Capital Expenditure10.55M7.66M326.00K2.50M57.00K129.00K124.00K657.00K7.40M
Free Cash Flow-51.16M-73.71M-86.92M-81.59M-89.84M-89.36M-94.03M-63.04M-71.43M
FCF to OCF125.98%111.59%100.38%103.16%100.06%100.14%100.13%101.05%111.56%

Earnings

Report DateJun 30, 2019Sep 30, 2019Feb 13, 2020May 13, 2020Aug 19, 2020Nov 3, 2020Feb 11, 2021Apr 19, 2021Aug 18, 2021Nov 17, 2021Feb 22, 2022May 24, 2022Aug 23, 2022Nov 22, 2022Feb 21, 2023May 23, 2023Aug 22, 2023Nov 21, 2023Feb 6, 2024May 14, 2024Aug 20, 2024Nov 12, 2024Feb 4, 2025May 6, 2025Aug 19, 2025Nov 4, 2025Feb 3, 2026May 5, 2026Aug 18, 2026Nov 3, 2026
EPS Estimate------0.00-----0.40-0.37-0.38------0.16-0.16-0.16-0.13-0.18-0.09-0.09-0.11-0.08-0.15-0.06
EPS Actual-0.78-0.84-1.23-0.78-0.96-1.10-0.54-0.80-0.44-0.29-0.50-0.40-0.40-0.30-0.50-0.33-0.28-0.37-0.60-0.10-0.20-0.10-0.10-0.10-0.10-0.10-0.20-0.10-0.10-
Surprise-----------0.00%-8.11%21.05%-----37.50%-25.00%37.50%23.08%44.44%-11.11%-11.11%-81.82%-25.00%33.33%-
Timing--Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap385.53M
Enterprise Value227.85M
Trailing P/E0.00
Forward P/E31.95
Price / Sales2.35
Price / Book1.32
EPS-0.50
Book Value2.60
Revenue (TTM)163.80M
Gross Profit (TTM)154.13M
EBITDA-51.34M
Profit Margin-31.11%
Operating Margin-32.69%
Return on Equity-16.14%
Return on Assets-8.53%
Shares Outstanding110.63M
Shares Float78.05M
Beta0.62
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%